European Archives - Page 810 of 1166 - European Medical Journal

Continue
11 Mins
20 Nov 2018

Update on the Management of Diabetic Dyslipidaemia

Diabetic dyslipidaemia is characterised by low levels of HDL-C, elevated levels of LDL-C, and a high prevalence of small dense LDL particles
9 Mins
20 Nov 2018

Efficacy of Wearable Devices to Measure and Promote Physical Activity in the Management of Diabetes

Physical inactivity is a global health problem that contributes to the increasing risk of obesity and diabetes. Wearable devices are defined as…
2 Mins
20 Nov 2018

Variants in Genes (DHCR7, CYP2R1, and GC) Regulating Vitamin D Metabolism Determine Low Vitamin D Levels in Type 2 Diabetic Patients

Hypovitaminosis D is associated with an increased prevalence and incidence of metabolic syndrome and Type 2 diabetes mellitus (T2DM).
2 Mins
20 Nov 2018

High Low-Density Lipoprotein Cholesterol Levels and Risk of Peripheral Vascular Diseases: A Mendelian Randomisation Study Including 116,419 Individuals From The General Population

High low-density lipoprotein (LDL) cholesterol levels are causally involved in the pathogenesis of atherosclerosis and are related to an increased risk…
10 Mins
20 Nov 2018

Low-Carbohydrate Diets and Glycaemic Control in Type 1 Diabetes Mellitus

In recent years the successful treatment of Type 2 diabetes mellitus through total calorific and/or dietary carbohydrate restriction has been well…
11 Mins
20 Nov 2018

Growth Hormone and Metabolic Homeostasis

This review provides an overview of the effects of pituitary growth hormone (GH) on glucose, lipid, and protein metabolism, insulin resistance, and metabolic homeostasis.
2 Mins
20 Nov 2018

Inhibition of Insulin Secretion by Cxcl14

G protein-coupled receptors are tractable targets for pharmacotherapies;1 however, challenges arise when it is necessary to either deorphanise a known…
10 Mins
20 Nov 2018

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Efficacy and Safety in the Treatment of Hypercholesterolaemia

Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9I) are a new class of medication that has recently arisen to combat hypercholesterolaemia.
2 Mins
20 Nov 2018

IRS1 Genetic Variants Associated with Glucose Control and Insulin Resistance in Type 2 Diabetes Mellitus Patients from Bosnia And Herzegovina

Previous studies have reported conflicting results regarding the association of IRS1 gene variation with Type 2 diabetes mellitus (T2DM) and insulin…
19 Nov 2018

Pushing the Frontiers of Neurology: The Impact of Microgravity

Space: The final frontier. However, it seems that this frontier may not remain unexplored from a neurological standpoint for that much longer, with a…
We’ve noticed you’re accessing
from North/South America.